Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
about
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicCombination HIV prevention: significance, challenges, and opportunitiesAntiviral therapy for genital herpes for prevention of HIV transmissionThe effects of antiviral therapy of genital herpes in HIV-infected individualsResistance to HIV InfectionHSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV InfectionHSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York CityPre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South AfricaModeling HIV transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapyHerpes simplex virus type 2 infection among young uncircumcised men in Kisumu, Kenya.In vitro anti-Herpes simplex virus activity of crude extract of the roots of Nauclea latifolia Smith (Rubiaceae).Herpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infectionInvesting in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South AfricaHigh-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trialEvaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.Discussion and revision of the mathematical modeling tool described in the previously published article "Modeling HIV Transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy"Group sex events and HIV/STI risk in an urban network.Modelling the impact of antiretroviral therapy on the epidemic of HIVHerpes simplex virus type 2: epidemiology and management options in developing countries.Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa.Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm.The increase of sexually transmitted infections calls for simultaneous preventive intervention for more effectively containing HIV epidemics in China.Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections.Seroprevalence of Herpes Simplex Virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti.Advances in multilevel approaches to understanding the epidemiology and prevention of sexually transmitted infections and HIV: an overview.Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.
P2860
Q22241890-996C43CE-34A7-499D-A985-85F2B52EE9F3Q22252603-CDB6A593-F162-4548-AEB2-454986617CB2Q24234315-88880F1E-BFEA-49D2-A39D-64634D751E19Q24245937-955CAA22-0ADD-4152-9993-EC21FECD93C1Q27473466-BE1434B9-E988-4A73-9CE5-4C5ABC319C85Q28534118-D0A634FD-37C5-4AA7-A968-53CDF8005941Q28539412-28B469F8-A1E4-4B42-8FEF-0DB90471DA2BQ30238750-BB0B460B-59D6-46F7-9895-873C62AA403EQ34168214-1645E9D5-B106-4B0D-B545-4596C0140CADQ34484127-DA1BE701-B9B3-4C04-9E64-4D4E8A7567AEQ34846776-4A46252C-A89A-4E63-9B13-DB8716E92BADQ35019283-2EE82110-E08E-4217-B8D0-2B40C6F14FD9Q35038122-76658EE8-1EA8-41C4-9525-08E4B152BEB5Q35062487-F42267F5-3556-4D5A-A6AE-28BC7F0E49D8Q35639207-B0AC92FE-1D58-45C8-BBBC-1A08AF0906CCQ35641538-A1BC7B1E-9A13-452A-9F1A-80071FE8ED62Q35973913-F153D765-4053-4ED7-8ED7-6BB0A6246B8EQ36135329-28C34DCE-BF68-4561-9978-D4A4D2601B26Q36486234-0BCC0300-1E4F-49C3-8289-60308258B1F5Q36650973-5AD5D500-42D0-4821-BCE9-69BE243F5E7CQ37014624-2D6C33D8-BC4A-43CC-9432-F6CD8C648290Q37033387-696FA108-2BCE-40F8-BCE0-88A9065E2D3FQ37405279-AB4673DE-E396-4C33-8A2E-E0033E24EF34Q37843246-842A93D8-9881-4734-9A4A-9713A54FC5D2Q37858678-942EB91A-3766-455F-A9BC-E90E32E9B725Q40087881-6DB4FBC1-D90B-4113-96AA-870A92E9110AQ43579033-979C23BA-7C4E-4FC7-B665-D3ED0793C729Q43932136-ED7D0141-DA8D-4651-9011-B9C350708B06
P2860
Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Potential effect of HIV type 1 ...... ition of HIV type 1 infection.
@ast
Potential effect of HIV type 1 ...... ition of HIV type 1 infection.
@en
type
label
Potential effect of HIV type 1 ...... ition of HIV type 1 infection.
@ast
Potential effect of HIV type 1 ...... ition of HIV type 1 infection.
@en
prefLabel
Potential effect of HIV type 1 ...... ition of HIV type 1 infection.
@ast
Potential effect of HIV type 1 ...... ition of HIV type 1 infection.
@en
P356
P1476
Potential effect of HIV type 1 ...... ition of HIV type 1 infection.
@en
P2093
Connie L Celum
Noah J Robinson
P304
P356
10.1086/425272
P407
P478
191 Suppl 1
P577
2005-02-01T00:00:00Z